Listed Pharma startups in Taiwan

Nikkei Biotech has published a list of pharma ventures in Taiwan. These are

Company name Security code Listing date Business
PharmaEssentia Corp 6446 2016 Treatment of erythrocyte hyperplasia etc. P1101 has already been launched in Europe, the U.S. and other markets
Polaris Group 6550 2022 Anti-cancer drugs. P3 study of ADI-PEG20, a treatment for malignant pleural mesothelioma
Oneness Biotech Co 4743 2011 Drugs for atopic dermatitis, etc. FB825 is licensed out to LEO Pharma
Lotus Pharmaceutical Co 1795 2010 Generic drugs for respiratory and neurological diseases. Affiliated with Alvogen of the U.S.
EirGenix Inc. 6589 2019 Biosimilars and contract manufacturing of biopharmaceuticals and coronavirus vaccine products
Medigen Vaccine Biologics Corp 6547 2018 Various vaccines for new coronas, influenza, hand-foot-and-mouth disease, etc.
Bora Pharmaceuticals Co 6472 2017 CDMO. Increased production capacity through acquisition of another company’s plant
PharmaEngine Inc 4162 2012 Subsidiary of Chi-Cing Pharmaceutical. Develops anti-cancer drugs. Onivade, a pancreatic cancer drug, is approved in Japan, the U.S. and Europe
ScinoPharm Taiwan 1789 2011 Leading manufacturer of API. Business alliance with Baxter. Affiliated with Taiwan’s major food company, Unification Corp.
Tanvex BioPharma Inc 6541 2017 Developer of biosimilars. Production bases in the U.S. and Taiwan. Affiliated with Taiwanese major Jun Tai

Taiwan has achieved an economic growth rate of over 6% in 2021 and expects economic growth in the 3% range in 2022. The total market capitalization of the top 10 drug discovery venture companies this year was NT$620 billion (approximately 19,7 billion €), more than double that of the previous year.

Listed Pharma startups in Taiwan
Scroll to top